Understanding how fast-cycling blood cells respond to DNA damage

The DNA damage response of fast-cycling erythroblasts

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10896253

This study is looking at how young red blood cells, which grow quickly, handle any damage to their DNA, and it aims to help us understand more about blood disorders like anemia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10896253 on NIH RePORTER

What this research studies

This research investigates the process of red blood cell formation, focusing on how rapidly dividing erythroblasts manage DNA damage during their development. By examining a specific stage in these cells' lifecycle, the study aims to uncover the relationship between fast cell division and DNA replication accuracy. The researchers will analyze early erythroid progenitors, known as colony-forming-unit-erythroid (CFU-e), to see how their quick transition to mature red blood cells affects their ability to repair DNA damage. This could provide insights into conditions like anemia and other blood disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with anemia or other erythroid disorders.

Not a fit: Patients with non-hematological conditions or those not affected by blood disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for anemia and related blood disorders.

How similar studies have performed: Previous research has shown promising results in understanding cell cycle dynamics and DNA damage responses in other cell types, suggesting potential for success in this area as well.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer GenesCancer-Promoting Gene
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.